Skip to main content

Table 1 Outcomes of glove single-port laparoscopy-assisted transanal total mesorectal excision

From: Glove single-port laparoscopy-assisted transanal total mesorectal excision for low rectal cancer: a preliminary report

 Patient#1Patient#2Patient#3Patient#4Patient#5Mean ± SD
Age (years)435868626659.4 ± 9.94
GenderFemaleMaleMaleFemaleMale
Body mass index (kg/m2)19.523.523.225.224.623.2 ± 2.22
ASA score11221
Underlying diseaseNoNoHBPNoNo
Previous abdominal operationNoNoNoNoNo
Distance from anal verge (cm)5.06.04.05.04.04.8 ± 0.84
Diameter of tumor (cm)1.53.02.02.52.02.2 ± 0.57
Tumor positionLeft lateralAnteriorPosteriorAnteriorAnterior
Neoadjuvant therapyYesNoNoNoNo
Operative time (min)280360400310340338.0 ± 46.04
Estimated blood loss (ml)5015050805076.0 ± 43.46
Length of specimen (cm)9.010.08.09.010.09.2 ± 0.84
Lymph nodes harvested121311121312.2 ± 0.84
(y)TNM stageyT1N0M0T3N1M0T1N0M0T2N0M0T2N1M0
Circumferential marginNegativeNegativeNegativeNegativeNegative
Bowel movement (days)323433.0 ± 0.71
LOS (days)8791098.6 ± 1.14
ConversionNoNoNoNoNo
ReoperationNoNoNoNoNo
ComplicationsNoStoma prolapseNoNoNo
30-day readmissionNoNoNoNoNo
Follow-up (months)17.016.014.015.012.014.8 ± 1.92
  1. ASA American Society of Anesthesiologists, HBP high blood pressure, (y) TNM stage for patients that received neoadjuvant chemoradiotherapy, LOS length of hospital stay